This announcement is a separate document:
日本新薬：2025年3月期 第2四半期(中間期）決算短信〔ＩＦＲＳ〕（連結）
Nippon Shinyaku: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [IFRS] (consolidated)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated